1. Home
  2. CAC vs FLGT Comparison

CAC vs FLGT Comparison

Compare CAC & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Camden National Corporation

CAC

Camden National Corporation

HOLD

Current Price

$45.52

Market Cap

680.5M

Sector

Finance

ML Signal

HOLD

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$26.97

Market Cap

697.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAC
FLGT
Founded
1875
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
680.5M
697.3M
IPO Year
1997
2016

Fundamental Metrics

Financial Performance
Metric
CAC
FLGT
Price
$45.52
$26.97
Analyst Decision
Buy
Buy
Analyst Count
3
3
Target Price
$47.33
$28.33
AVG Volume (30 Days)
72.7K
272.3K
Earning Date
01-27-2026
11-07-2025
Dividend Yield
3.72%
N/A
EPS Growth
9.13
N/A
EPS
3.49
N/A
Revenue
$215,172,000.00
$315,549,000.00
Revenue This Year
$44.50
$16.84
Revenue Next Year
$7.03
$9.74
P/E Ratio
$12.94
N/A
Revenue Growth
27.50
13.61
52 Week Low
$34.53
$14.57
52 Week High
$46.99
$31.04

Technical Indicators

Market Signals
Indicator
CAC
FLGT
Relative Strength Index (RSI) 77.21 45.25
Support Level $41.38 $26.69
Resistance Level $41.60 $31.04
Average True Range (ATR) 1.24 0.74
MACD 0.39 -0.45
Stochastic Oscillator 95.25 7.59

Price Performance

Historical Comparison
CAC
FLGT

About CAC Camden National Corporation

Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Share on Social Networks: